novo nordisk glp 1 GoodRx, team to make GLP-1 meds affordable A New Era of Weight

Dipeptidyl-peptidase IV inhibitors (DPP4i)-associated bullous pemphigoid: estimating the clinical profile and exploring intraclass differences

Mindful Eating as a Tool for Diabetes Prevention and Management: A Review of Potential Mechanisms of Action

Adults 65 and older have the highest diabetes rate of any age group, about 29%, yet their GLP-1 use drops to 9%, below the middle-aged group and below the national average

For time efficiency, brief questionnaires that assess multiple lifestyle behaviors include the Lifestyle Medicine Assessment [129] and Lifestyle Medicine Health Behavior Scale [130]

Employer contributions start at a minimum of $50 per fill with no ceiling, bringing employee out-of-pocket costs down to as little as $213.99 per fill at a $300 employer contribution

Mechanistic data on GLP-1R/GIPR/GCGR tri-agonists The combination of GLP-1RA, GIPRA, and GCGRA in preclinical studies has demonstrated superior weight loss relative to liraglutide in mice with diet-induced obesity, attributed to decreased food intake and increased energy expenditure (Baggio & Drucker 2021)